Effect of angiotensin infusion during pregnancy on fetal heart rate and on fetal activity.
The angiotensin sensitivity test is of value in predicting patients at increased risk of pregnancy-induced hypertension and preeclampsia. Studies on the effects of angiotensin II on uterine blood flow in various species showed contradicting results. In the present study, 15 pregnant women were monitored by cardiotocography before, during and after an infusion of angiotensin II-amide (maximal infusion rates 6.3--23.2 ng . kg-1. min-1). No remarkable changes in fetal heart rate, oscillatory frequency and amplitude, as well as in the number of accelerations and fetal movements could be observed. It may be concluded from these results that the fetal condition is not compromised by an angiotensin sensitivity test.
D000328:Adult; D000804:Angiotensin II / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D009068:Movement / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis
D000804:Angiotensin II